Amivas wins FDA approval for critical severe malaria drug May 27, 2020 By Michael Fitzhugh No Comments Intravenous artesunate, the international standard of care to treat severe malaria, has finally won full FDA approval for the condition, which affects about 300 of the approximately 2,000 people diagnosed with malaria in the U.S. each year.Read More